Some quick good news this morning:
The Supreme Court says companies cannot patent human genes, a decision that could profoundly affect the medical and biotechnology industries. In a unanimous decision, the court struck down patents held by Myriad Genetics Inc. on two genes linked to increased risk of breast and ovarian cancer.
This is a victory for common sense. The fact that it was unanimous suggests a ray of hope for patent law in the future.